malondialdehyde has been researched along with vinpocetine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bedi, KL; Deshmukh, R; Mehan, S; Sharma, N; Sharma, V | 1 |
| Ding-Sheng, L; Sen-Min, W; Xiao-Xiao, T | 1 |
| Gupta, S; Sharma, B; Sharma, BM; Singh, P | 1 |
| Abdel-Sattar, SA; Ahmed, HI; Zaky, HS | 1 |
| Komaki, A; Raoufi, S; Salehi, I; Sarihi, A; Shahidi, S; Shekarian, M | 1 |
| Abdelrahman, RS; Abozaid, AM; Elnfarawy, AA; Elweshahy, RH; Komber, IF; Nashy, AE | 1 |
6 other study(ies) available for malondialdehyde and vinpocetine
| Article | Year |
|---|---|
Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Glutathione; L-Lactate Dehydrogenase; Male; Malondialdehyde; Maze Learning; Memory; Motor Activity; Nitrites; Oxidative Stress; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Streptozocin; Vinca Alkaloids | 2009 |
Effects of vinpocetine on random skin flap survival in rats.
Topics: Animals; Disease Models, Animal; Graft Survival; Immunohistochemistry; Male; Malondialdehyde; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Sensitivity and Specificity; Skin Transplantation; Superoxide Dismutase; Surgical Flaps; Vascular Endothelial Growth Factor A; Vinca Alkaloids | 2013 |
Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.
Topics: Acetamides; Acetylcholinesterase; Analysis of Variance; Animals; Arterial Occlusive Diseases; Brain; Catalase; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Superoxide Dismutase; Time Factors; Vinca Alkaloids | 2015 |
Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Glycogen Synthase Kinase 3 beta; Hippocampus; Ketamine; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Schizophrenia; Signal Transduction; Vinca Alkaloids | 2018 |
The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cyclic Nucleotide Phosphodiesterases, Type 1; Disease Models, Animal; Glutathione; Injections, Intraventricular; Learning; Malondialdehyde; Memory; Memory Disorders; Morris Water Maze Test; Nitrites; Oxidative Stress; Phosphodiesterase Inhibitors; Rats; Spatial Memory; Vinca Alkaloids | 2020 |
Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Glutathione; Interleukin-6; Liver; Liver Cirrhosis; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Superoxide Dismutase; Thioacetamide; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2021 |